This recruiting study focuses on bipolarity and currently lists sites or participation links in United States.
This study exists to explore whether the medication Spoken could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory. The findings could guide better understanding and future care, and taking part helps build that evidence for others.
The official record suggests in-person participation through a clinic, with sites including Mayo Clinic Minnesota in Rochester. Participation appears to involve study activities and check-ins designed to see how this approach works in practice. The main fit is usually being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordTaking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in United States.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com